Epicor® postbiotic

Overview

EpiCor is produced through a proprietary fermentation process using Saccharomyces cerevisiae. The resulting dried fermentate contains a complex matrix of metabolites, proteins, polyphenols, and beta-glucans that have demonstrated immunomodulatory and prebiotic activity in human clinical trials. Over 15 peer-reviewed studies support its efficacy for immune health, gut microbiome modulation, and upper respiratory health. The ingredient is FDA GRAS, heat-stable, pH-tolerant, and carries a three-year shelf life.

Technical specifications

• Source organism: Saccharomyces cerevisiae dried fermentate
• Clinical evidence: 15+ peer-reviewed human studies covering immune health, gut microbiome, and upper respiratory outcomes
• Regulatory: FDA GRAS
• Stability: heat-stable, pH-tolerant, three-year shelf life
• Dosage: 500mg/day (standard clinical dose)
• Formats: capsules, tablets, gummies, powdered beverages, bars, and functional food applications
• Market position: #1 postbiotic ingredient globally by number of formulated products

Technology readiness level

TRL 9 — fully commercialized with extensive clinical validation and global distribution.